Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma
Crossref DOI link: https://doi.org/10.1007/s40265-017-0837-7
Published Online: 2017-11-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blair, Hannah A.
License valid from 2017-11-10